Logout Login Cart iconShop Contact Sales

Search

Filters

Content Type

Products

Clear Filters

Search Results for "certificate of analysis"

Looking for quality documents?
news icon
Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines
external link icon
Repligen Announces Pricing of $100 Million of 2.125% Convertible Senior Notes due 2021
WALTHAM, Mass., May 19, 2016 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN) (the “Company”) today announced the pricing of an underwritten public offering of $100 million aggregate principal amount of 2.125% Convertible Senior Notes due 2021 (the “Notes”). The Company has granted the underwriters a 30-day option to purchase up to an additional $15 million aggregate principal amount of Notes. The offering is expected to close on or about May 24, 2016, subject to customary closing conditions. Jefferies is acting as the sole book-running manager, and Janney Montgomery Scott and Craig-Hallum Capital Group are acting as co-managers in the offering.  Perella Weinberg Partners LP and J. Wood Capital Advisors LLC are serving as financial advisors to the Company in connection with the offering.
Interest on the Notes will be paid semiannually in arrears on June 1 and December 1 of each year at the rate of 2.125% per year, beginning on December 1, 2016. The Notes will
external link icon
Karen A. Dawes Elected as Repligen Co-chairperson of the Board of Directors
news icon
Repligen Launches Single-use Version of its Cell Retention Technology
news icon
UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report
news icon
Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report
news icon
Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report
event icon
Strategic considerations to future-proof single-use assemblies
The advantages of single-use flow paths can be impaired by design, component sourcing, quality and lead-time challenges. Repligen has built new start-of-the-art facilities and assembled a unique set of both plastic and valve technologies that enable rapid design and manufacture of complex flow paths with flow control at high capacity. This webinar will discuss how vertical supply chain security, facility design, expert consultation and advanced componetry deliver differentiated single-use solutions
news icon
Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements
external link icon
Repligen Announces Proposed Public Offering of $100 Million of Convertible Senior Notes due 2021
WALTHAM, Mass., May 18, 2016 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN) (the “Company”) has commenced an offering of $100 million aggregate principal amount of Convertible Senior Notes due 2021 (the “Notes”) in an underwritten offering which includes the grant to the underwriter of a 30-day option to purchase up to an additional $15 million aggregate principal amount of Notes.  Jefferies is the sole book-running manager for the offering. 
The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.  The Notes will be issued and sold pursuant to an automatically effective shelf registration statement (including a base prospectus) that was previously filed with the Securities and Exchange Commission (“SEC”). A preliminary prospectus supplement relating to this offering will be filed with the SEC. When available, copies of the